Exaled nitric oxide (FeNO) is considered a good noninvasive marker to assess airway inflammation in asthma and allergic rhinitis. In asthma, exhaled NO is very useful to verify adherence to therapy, and to predict upcoming asthma exacerbations. It has been also proposed that adjusting anti-inflammatory drugs guided by the monitoring of exhaled NO, could improve overall asthma control. Other studies showed increased FeNO levels in subjects with allergic rhinitis.
|Number of pages||4|
|Journal||International Journal of Immunopathology and Pharmacology|
|Publication status||Published - Oct 1 2011|
- allergic rhinitis
- fractional exhaled nitric oxide and children
ASJC Scopus subject areas
- Immunology and Allergy